Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails.
This report contains market size and forecasts of Anti-fungal Drugs in Global, including the following market information:
- Global Anti-fungal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-fungal Drugs market was valued at 1770.4 million in 2021 and is projected to reach US$ 2075.4 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-fungal Drugs include Abbott Laboratories, Astellas Pharma, Bayer, GlaxoSmithKline, Glenmark, Kramer Laboratories, Merck, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-fungal Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-fungal Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-fungal Drugs Market Segment Percentages, by Type, 2021 (%)
- Powder
- Ointment
- Tablet
- Other
Global Anti-fungal Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-fungal Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Retail Pharmacy
- Online Pharmacy
Global Anti-fungal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-fungal Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anti-fungal Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Anti-fungal Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Astellas Pharma
- Bayer
- GlaxoSmithKline
- Glenmark
- Kramer Laboratories
- Merck
- Novartis
- Pfizer
- SCYNEXIS
- Sanofi
- Gilead Science
- Enzon Pharmaceuticals
